Netcells makes use of PrepaCyte-CB (Cord Blood)® processing technology when processing the cord blood stem cells.
It was developed in 2009 in the US, specifically for the processing of cord blood. It is a sterile, US FDA 510k approved closed processing system. Netcells chose to adopt this processing method because it recovers more colony forming stem cells, has lower levels of red blood cells post processing and stem cells processed with this method offer a quicker time to engraftment, than other cord blood processing methods1.
PrepaCyte-CB® leads to better separation of the red blood cells from the plasma and white blood cells by a process called sedimentation.
It creates a clear physical difference in separation of cell types, which means it is able to capture more stem cells whilst reducing red blood cells by up to 99%.